- Just Diagnosed
- What is NMO?
- NMO Publications
- Articles
- Spectrum Newsletter>
- Recommended Reading
- Find NMO Clinicians
- Share Your NMO Story
- Living with NMO
- NMO Publications
- Articles
- Spectrum Newsletter>
- Recommended Reading
- Participate
- Find NMO Clinicians
- Upcoming Events
- Share Your NMO Story
- NMO Publications
- Clinicians
- Scientists
- Scientific Publications
- Articles
- Spectrum Newsletter>
- Recommended Reading
- Blood Bank
- Critical Questions
- Clinical Trials
- Upcoming Events
- Blog Your Expertise
- Scientific Publications
I built and maintain Spectrum for the Foundation.
Bookmarked item
Steve Ornburn 1065 days ago
The linked resource is bookmard on the Internet. Please click the "Visit Resource" button below to read the full story.
"Genentech must get Biogen Idec's approval before it can continue drug-development projects for multiple sclerosis, cancer and a blindness disease called neuromyelitis optica, an arbitration panel ruled."
A Rare Approach to a Rare Disease
Powered by Elgg, the leading open-source social-networking platform
Developed by the All Greater Good Foundation
